Click here to view cell apoptosis assay products
×

Recombinant Human PD-L1/B7-H1/CD274 Protein (His Tag)

Uniprot : Q9NZQ7
  • Cat.No.:PKSH033557

  • Expression host: HEK293 Cells

To Purchase PKSH033557

Size:
  • 10µg
  • 50µg
Price: $49
Qty:

Description

Synonyms Programmed Cell Death 1 Ligand 1;PD-L1;PDCD1 Ligand 1;Programmed Death Ligand 1;B7 Homolog 1;B7-H1;CD274;B7H1;PDCD1L1;PDCD1LG1;PDL1
Species Human
Expression_host HEK293 Cells
Sequence Phe19-Thr239
Accession Q9NZQ7
Application Functional ELISA
Mol_Mass 26.3 kDa
AP_Mol_Mass 34-42 kDa
Tag C-His
Bio_Activity Immobilized Anti-Human PDL1 mAb at 2μg/ml (100 μl/well)can bind Human PD-L1-His.The ED50 of Human PD-L1-6His is 5.57 ng/ml.

Properties

Purity > 95 % as determined by reducing SDS-PAGE.
Endotoxin level < 1.0 EU per μg of the protein as determined by the LAL method.
Storage Generally, lyophilized proteins are stable for up to 12 months when stored at -20 to -80℃. Reconstituted protein solution can be stored at 4-8℃ for 2-7 days. Aliquots of reconstituted samples are stable at < -20℃ for 3 months.
Shipping This product is provided as lyophilized powder which is shipped with ice packs.
Formulation Lyophilized from a 0.2 μm filtered solution of 20mM PB, 4% Mannitol, 0.02% Tween 80, pH7.4.
Normally 5 % - 8 % trehalose, mannitol and 0.01% Tween80 are added as protectants before lyophilization.
Please refer to the specific buffer information in
Reconstitution Please refer to the printed manual for detailed information.

Background

CD274; also known as B7-H1 or programmed death ligand 1 (PD-L1); is a 40 kD type I transmembrane protein and a member of the B7 family within the immunoglobulin receptor superfamily. Programmed death-1 ligand-1 (PD-L1; CD274; B7-H1) has been identified as the ligand for the immunoinhibitory receptor programmed death-1(PD1/PDCD1) and has been demonstrated to play a role in the regulation of immune responses and peripheral tolerance. By binding to PD1 on activated T-cells and B-cells; PD-L1 may inhibit ongoing T-cell responses by inducing apoptosis and arresting cell-cycle progression. Accordingly; it leads to growth of immunogenic tumor growth by increasing apoptosis of antigen specific T cells and may contribute to immune evasion by cancers. PD-L1 thus is regarded as promising therapeutic target for human autoimmune disease and malignant cancers.

Related Products

Citations

Reviews/Q&A

  • Show all
  • Reviews
  • Q&A
... Show All Show Less

People Also Bought

Apply for
*Product Name:
*Catalog Number:
*Name:
*Email:
*Message:
*Country:
*When will you use it?

*Captcha: